VERTEX PHARMACEUTICALS INC / MA (VRTX) Net income 2016–2025
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$4.0BFY2025 · since FY2016: -$112.1M → $4.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.0B | +838.1% |
| FY2024 | -$535.6M | -114.8% |
| FY2023 | $3.6B | +9.0% |
| FY2022 | $3.3B | +41.8% |
| FY2021 | $2.3B | -13.6% |
| FY2020 | $2.7B | +130.4% |
| FY2019 | $1.2B | -43.9% |
| FY2018 | $2.1B | +695.8% |
| FY2017 | $263.5M | +335.1% |
| FY2016 | -$112.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice